Singapore markets open in 1 hour 22 minutes

Neumora Therapeutics, Inc. (NMRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.69+0.02 (+0.21%)
At close: 04:00PM EDT
9.69 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
222,895
206,623
104,749
212,776
87,126
Selling general and administrative
50,109
45,475
31,121
24,547
8,392
Total operating expenses
273,004
252,098
135,870
237,323
95,518
Operating income or loss
-273,004
-252,098
-135,870
-237,323
-95,518
Total other income/expenses net
-156
-170
405
11
-3,754
Income before tax
-253,753
-235,657
-130,904
-237,312
-99,272
Income tax expense
-
268
0
-
-
Income from continuing operations
-254,021
-235,925
-130,904
-237,312
-99,272
Net income
-254,021
-235,925
-130,904
-237,312
-99,272
Net income available to common shareholders
-254,021
-235,925
-130,904
-237,312
-99,272
Basic EPS
-1.02
-3.63
-4.81
-1.56
-0.65
Diluted EPS
-1.02
-3.63
-4.81
-1.56
-0.65
Basic average shares
151,949
65,021
27,207
151,949
151,949
Diluted average shares
151,949
65,021
151,949
151,949
151,949